180 related articles for article (PubMed ID: 1680846)
21. Effect of buthionine sulfoximine, an inhibitor of glutathione biosynthesis, on the selenium-induced lethality in mice.
Ishikawa M; Takayanagi G; Sasaki K
Jpn J Pharmacol; 1988 Oct; 48(2):283-6. PubMed ID: 3210451
[TBL] [Abstract][Full Text] [Related]
22. Transport into brain of buthionine sulfoximine, an inhibitor of glutathione synthesis, is facilitated by esterification and administration of dimethylsulfoxide.
Steinherz R; Mårtensson J; Wellner D; Meister A
Brain Res; 1990 Jun; 518(1-2):115-9. PubMed ID: 2390716
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cisplatin-induced nephrotoxicity in rats by buthionine sulfoximine, a glutathione synthesis inhibitor.
Mayer RD; Lee KE; Cockett AT
Cancer Chemother Pharmacol; 1987; 20(3):207-10. PubMed ID: 2890443
[TBL] [Abstract][Full Text] [Related]
24. Effects of buthionine sulfoximine (BSO) on mercury distribution after Hg(o) exposure.
Kim CY; Watanabe C; Satoh H
Toxicology; 1995 Apr; 98(1-3):67-72. PubMed ID: 7740555
[TBL] [Abstract][Full Text] [Related]
25. Lack of effect of glutathione depletion by L-buthionine-S,R-sulfoximine on gentamicin nephrotoxicity in rats.
Wu DF; Griffith OW; Reidenberg MM
Pharmacology; 1990; 40(5):250-7. PubMed ID: 2274571
[TBL] [Abstract][Full Text] [Related]
26. Effect of buthionine sulfoximine on acute N-(3,5-dichlorophenyl)succinimide-induced nephrotoxicity in Fischer 344 rats.
Rankin GO; Teets VJ; Nicoll DW; Brown PI
Toxicol Lett; 1990 Jun; 52(1):91-100. PubMed ID: 2356574
[TBL] [Abstract][Full Text] [Related]
27. Induction of rat UDP-glucuronosyltransferase and glutathione S-transferase activities by L-buthionine-S,R-sulfoximine without induction of cytochrome P-450.
Manning BW; Franklin MR
Toxicology; 1990 Dec; 65(1-2):149-59. PubMed ID: 2125759
[TBL] [Abstract][Full Text] [Related]
28. Glutathione biosynthesis in the isolated perfused rat lung: utilization of extracellular glutathione.
Berggren M; Dawson J; Moldéus P
FEBS Lett; 1984 Oct; 176(1):189-92. PubMed ID: 6149151
[TBL] [Abstract][Full Text] [Related]
29. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
[TBL] [Abstract][Full Text] [Related]
30. Depletion of glutathione by inhibition of biosynthesis.
Griffith OW
Methods Enzymol; 1981; 77():59-63. PubMed ID: 6120437
[No Abstract] [Full Text] [Related]
31. Inhibition of glutathione synthesis of Ascaris suum by buthionine sulfoximine.
Hussein AS; Walter RD
Parasitol Res; 1996; 82(4):372-4. PubMed ID: 8740556
[TBL] [Abstract][Full Text] [Related]
32. Buthionine sulfoximine protects the viability of adult rat Leydig cells exposed to ethane dimethanesulfonate.
Kelce WR
Toxicol Appl Pharmacol; 1994 Apr; 125(2):237-46. PubMed ID: 8171431
[TBL] [Abstract][Full Text] [Related]
33. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
[TBL] [Abstract][Full Text] [Related]
34. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
Kang YJ
Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
[TBL] [Abstract][Full Text] [Related]
35. Depletion of glutathione selectively inhibits synthesis of leukotriene C by macrophages.
Rouzer CA; Scott WA; Griffith OW; Hamill AL; Cohn ZA
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2532-6. PubMed ID: 6113592
[TBL] [Abstract][Full Text] [Related]
36. Buthionine sulfoximine diverts the melanogenesis pathway toward the production of more soluble and degradable pigments.
Galván I; Wakamatsu K; Alonso-Alvarez C; Solano F
Bioorg Med Chem Lett; 2014 May; 24(9):2150-4. PubMed ID: 24703231
[TBL] [Abstract][Full Text] [Related]
37. Pharmacodynamics of prolonged treatment with L,S-buthionine sulfoximine.
Malaker K; Hurwitz SJ; Bump EA; Griffith OW; Lai LL; Riese N; Coleman CN
Int J Radiat Oncol Biol Phys; 1994 May; 29(2):407-12. PubMed ID: 7910818
[TBL] [Abstract][Full Text] [Related]
38. Changes in rat liver gene expression induced by thioacetamide: protective role of S-adenosyl-L-methionine by a glutathione-dependent mechanism.
Mesa ML; Carrizosa R; Martínez-Honduvilla C; Benito M; Fabregat I
Hepatology; 1996 Mar; 23(3):600-6. PubMed ID: 8617442
[TBL] [Abstract][Full Text] [Related]
39. Arsenic increased lipid peroxidation in rat tissues by a mechanism independent of glutathione levels.
Ramos O; Carrizales L; Yáñez L; Mejía J; Batres L; Ortíz D; Díaz-Barriga F
Environ Health Perspect; 1995 Feb; 103 Suppl 1(Suppl 1):85-8. PubMed ID: 7621808
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis.
Griffith OW
J Biol Chem; 1982 Nov; 257(22):13704-12. PubMed ID: 6128339
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
